ABG

Ally Bridge Group Portfolio holdings

AUM $114M
This Quarter Return
+0.69%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$305M
AUM Growth
+$305M
Cap. Flow
-$11.4M
Cap. Flow %
-3.75%
Top 10 Hldgs %
57.82%
Holding
36
New
8
Increased
4
Reduced
7
Closed
6

Top Buys

1
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
$9.91M
2
RPID icon
Rapid Micro Biosystems
RPID
$8.09M
3
SGHT icon
Sight Sciences
SGHT
$7.77M
4
NTRA icon
Natera
NTRA
$5.57M
5
MGNX icon
MacroGenics
MGNX
$5.28M

Top Sells

1
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$17.3M
2
EPIX icon
ESSA Pharma
EPIX
$10.4M
3
AVIR icon
Atea Pharmaceuticals
AVIR
$8.02M
4
CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
$5.39M
5
APLS icon
Apellis Pharmaceuticals
APLS
$5.37M

Sector Composition

1 Healthcare 96.55%
2 Materials 1.59%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CELL
26
DELISTED
PhenomeX Inc. Common Stock
CELL
$3.95M 1.16%
+201,996
New +$3.95M
ACET icon
27
Adicet Bio
ACET
$60.8M
$3.33M 0.98%
425,000
– –
BOLT icon
28
Bolt Biotherapeutics
BOLT
$9.29M
$3.25M 0.96%
12,863
-7,750
-38% -$1.96M
VERV
29
DELISTED
Verve Therapeutics
VERV
$705K 0.21%
+15,000
New +$705K
APLS icon
30
Apellis Pharmaceuticals
APLS
$3.51B
– –
-85,000
Closed -$5.37M
AVIR icon
31
Atea Pharmaceuticals
AVIR
$275M
– –
-373,288
Closed -$8.02M
EPIX icon
32
ESSA Pharma
EPIX
$11.2M
– –
-363,185
Closed -$10.4M
SPRY icon
33
ARS Pharmaceuticals
SPRY
$1.08B
– –
-128,572
Closed -$3.97M
XNTK icon
34
SPDR NYSE Technology ETF
XNTK
$1.24B
– –
0
– –
CERE
35
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-675,670
Closed -$17.3M
FRLN
36
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
– –
-26,783
Closed -$3.27M
1
2